Acute stress enhances anxiolytic-like drug responses of mice tested in a black and white test box

European Neuropsychopharmacology

Volumn 7, Issue 4, 1997, Pages 283-288

  Sánchez, Connie ^a  

^a H LUNDBECK A S   (Denmark)

Author keywords

Anxiolytic; Mice; Stress

Indexed keywords

ANXIOLYTIC AGENT; BUSPIRONE; DIAZEPAM; ELTOPRAZINE; RITANSERIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DRUG EFFECT; DRUG RESPONSE; EXPERIMENT; EXPLORATORY BEHAVIOR; FACILITATION; MALE; MENTAL STRESS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; SHOCK; SUBCUTANEOUS DRUG ADMINISTRATION; SUSPENSION; SWIMMING;

ANIMALS; ANTI-ANXIETY AGENTS; DIAZEPAM; MALE; MICE; MOTOR ACTIVITY; PIPERAZINES; SEROTONIN AGONISTS; STRESS;

EID: 0342460480     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-977X(97)00035-7     Document Type: Article

References (16)

1. Carli M., Prontera C., Saminin R. Evidence that central 5-hydroxytryptaminergic neurones are involved in the anxiolytic activity of buspirone. Br. J. Pharmacol. 96:1989;829-836.
2. Costall B., Jones B.J., Kelly M.E., Naylor R.J., Tomkins D.M. Exploration of mice in a black and white test box: Validation as a model of anxiety. Pharmacol. Biochem. Behav. 32:1989;777-785.
3. Crawley J.N., Goodwin F.K. Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines. Pharmacol. Biochem. Behav. 13:1980;167-170.
4. 1A and benzodiazepine receptors in the basolateral amygdala modulate anxiety in the social interaction test, but not in the elevated plus-maze. Brain Res. 732:1996;145-153.
5. Graeff F.G., Viana M.B., Mora P.O. Opposed regulation by dorsal raphe nucleus 5-HT pathways of two types of fear in the elevated T-maze. Pharmacol. Biochem. Behav. 53:1996;171-177.
6. 1A receptor-mediated responses. Eur. J. Pharmacol. 222:1992;121-127.
7. Kilfoil T., Michel A., Montgomery D., Whiting R.L. Effects of anxiolytic and anxiogenic drugs on exploratory activity in a simple model of anxiety in mice. Neuropharmacology. 28:1989;901-905.
8. Kshama D., Hrishikeshavan H.J., Shanbhogue R., Munonyedi U.S. Modulation of baseline behavior in rats by putative serotonergic agents in three ethoexperimental paradigms. Behav. Neur. Biol. 54:1990;234-253.
9. López-Rubalcava C., Sáldivar A., Fernández-Guasti A. Interaction of GABA and serotonin in the anxiolytic action of diazepam and serotonergic anxiolytics. Pharmacol. Biochem. Behav. 43:1992;433-440.
10. 1A ligands, 8-OH-DPAT and MDL 73005EF, in mice. Neuro Report. 1:1990;267-270.
11. Olivier, B., Mos, J., Raghoebar, M., De Koning, P. and Mak, M., 1994. Serenics. Birkhäuser Verlag, Basel.
12. Onaivi E.S., Martin B.R. Neuropharmacological and physiological validation of a computer-controlled two-compartment black and white box for the assessment of anxiety. Prog. Neuropsychopharmacol. Biol. Psychiatr. 13:1989;963-976.
13. Pesold C., Treit D. The central and basolateral amygdala differentially mediate the anxiolytic effects of benzodiazepines. Brain Res. 67:1995;213-221.
14. Rodgers R.J., Cole J.C. Anxiety enhancement in the murine elevated plus maze by immediate prior exposure to social stressors. Physiol. Behav. 53:1993;383-388.
15. Sánchez C. Serotonergic mechanisms involved in the exploratory behavior of mice in a fully automated two-compartment black and white test box. Pharmacol. Toxicol. 77:1995;71-78.
16. 1A antagonistic potency of (-)-penbutolol in anxiety models is influenced by its β-adrenoceptor blocking properties. Eur. J. Pharmacol. 297:1996;1-8.